- Home
- BTBD vs PAVM Comparison
BTBD vs PAVM Comparison
Compare BTBD & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTBD | PAVM |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 7.1M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BTBD | PAVM |
|---|---|---|
| Price | $1.28 | $10.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 28.6K | ★ 3.0M |
| Earning Date | 03-30-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,038,307.00 | $29,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $6.00 |
| 52 Week High | $5.60 | $28.44 |
Technical Indicators
Market Signals| Indicator | BTBD | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 59.18 |
| Support Level | $1.15 | $9.21 |
| Resistance Level | $1.30 | $11.34 |
| Average True Range (ATR) | 0.10 | 1.38 |
| MACD | -0.01 | -0.21 |
| Stochastic Oscillator | 41.95 | 50.60 |
Price Performance
Historical ComparisonAbout BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.